Bone Marrow Transplant
Bone Marrow Transplant
We’re here for you. Call us at 844-346-7222 or
find a clinical trial
If you have any questions or are interested in participating in one of our Clinical Trials, please take note of the associated protocol number and contact our team at (201) 518-3587, or email us at email.
30
Clinical Trials
Bone Marrow Transplant
N/A
Enrolling
nct/study# N/A / CD34-REAGENT-SYSTEM-GVHD
This protocol is for the use of CliniMACS CD34 Reagent System in a single patient with relapsed AML. Patient received salvage chemo and planned stem cell boost for cytopenias. Since donor is a haplo, plan is to give CD34 selected cells with some t cell add back.
Learn More
Bone Marrow Transplant
N/A
Enrolling
nct/study# N/A / 00-05-187
Consent to Submit Hematopoietic Stem Cell Transplant Data to Transplant Registries.
Learn More
Bone Marrow Transplant
N/A
Enrolling
nct/study# NCT05201781 / 68284528MMY4002
Long-term Follow-up Study for Participants Previously Treated with Ciltacabtagene Autoleucel .
Learn More
Bone Marrow Transplant
N/A
Enrolling
nct/study# NCT05346835 / 68284528MMY4006
Intermediate-Size Population Expanded Access Program (EAP) for Ciltacabtagene autoleucel (cilta-cel) Out-of-Specification (OOS) in patients with Multiple Myeloma
Learn More
Bone Marrow Transplant
N/A
Enrolling
nct/study# N/A / ABATACEPT-ATG-AGVHD
Impact of Adding Abatacept to Antithymocyte Globulin for Acute Graft-Versus-Host Disease Prophylaxis in Matched Unrelated Donor Hematopoietic Stem Cell Transplantation
Learn More
Bone Marrow Transplant
Phase IV
Enrolling
nct/study# NCT06799221 / AUTO1-OS1
Expanded Access Program (EAP) for Obecabtagene Autoleucel (obe-cel) Out-of-specification (OOS) in Adult Patients with Acute Lymphoblastic Leukemia
Learn MoreWe are here for you
For more information or to schedule an appointment, call (844) 346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.